PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Applied Health Research, University of Birmingham, Birmingham, UK.\', \'Department of Diabetes, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'Cegedim Health Data, Cegedim Rx, London, UK.\', \'The Health Improvement Network (THIN), London, UK.\', \'Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.\', \'Department of Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.\', \'Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Midlands Health Data Research UK, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dom.14203
?:hasPublicationType
?:journal
  • Diabetes, obesity & metabolism
is ?:pmid of
?:pmid
?:pmid
  • 32991065
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Sodium-glucose co-transporter-2 inhibitors and susceptibility to COVID-19: A population-based retrospective cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32991065>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32991065>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all